A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients

Renal transplant recipients who are chronically immunosuppressed by drugs are at a higher risk of developing malignancies. Commonly observed malignancies are several forms of posttransplant lymphoproliferative disorders (PTLD), skin, lip and gynaecological cancers. The risk is associated with many r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Maradit Kremers, Hilal (VerfasserIn) , Funch, Donnie P. (VerfasserIn) , Robson, Richard A. (VerfasserIn) , Nalesnik, Michael A. (VerfasserIn) , Ebrahim, Shah (VerfasserIn) , Cecka, Michael J. (VerfasserIn) , Opelz, Gerhard (VerfasserIn) , Dreyer, Nancy A. (VerfasserIn) , Walker, Alexander M. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 January 2000
In: Pharmacoepidemiology and drug safety
Year: 1999, Jahrgang: 8, Heft: 7, Pages: 509-518
ISSN:1099-1557
DOI:10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1
Volltext
Verfasserangaben:Hilal Maradit Kremers, Donnie P. Funch, Richard A. Robson, Michael A. Nalesnik, Shah Ebrahim, Michael J. Cecka, Gerhard Opelz, Nancy A. Dreyer, Alexander M. Walker

MARC

LEADER 00000caa a2200000 c 4500
001 1748693662
003 DE-627
005 20230427070953.0
007 cr uuu---uuuuu
008 210219r20001999xx |||||o 00| ||eng c
024 7 |a 10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1  |2 doi 
035 |a (DE-627)1748693662 
035 |a (DE-599)KXP1748693662 
035 |a (OCoLC)1341394020 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Maradit Kremers, Hilal  |e VerfasserIn  |0 (DE-588)1227744498  |0 (DE-627)1748696033  |4 aut 
245 1 2 |a A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients  |c Hilal Maradit Kremers, Donnie P. Funch, Richard A. Robson, Michael A. Nalesnik, Shah Ebrahim, Michael J. Cecka, Gerhard Opelz, Nancy A. Dreyer, Alexander M. Walker 
264 1 |c 20 January 2000 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.02.2021 
520 |a Renal transplant recipients who are chronically immunosuppressed by drugs are at a higher risk of developing malignancies. Commonly observed malignancies are several forms of posttransplant lymphoproliferative disorders (PTLD), skin, lip and gynaecological cancers. The risk is associated with many risk factors including the extent of immunosuppression. Mycophenolate mofetil (MMF) is an immunosuppressant, indicated for the prophylaxis of organ rejection in patients receiving allogenic renal and heart transplants. During the European approval of MMF for renal transplantation, the question was raised as to whether the use of MMF was associated with an increased risk of PTLD in comparison with alternate immunosuppressive regimens. In response, F. Hoffman-La Roche Ltd set up a prospective observational cohort study with a companion case-control study. This paper describes the objectives and the methods of these studies along with the rationale of the methodology. 
534 |c 1999 
700 1 |a Funch, Donnie P.  |e VerfasserIn  |4 aut 
700 1 |a Robson, Richard A.  |e VerfasserIn  |4 aut 
700 1 |a Nalesnik, Michael A.  |e VerfasserIn  |4 aut 
700 1 |a Ebrahim, Shah  |e VerfasserIn  |4 aut 
700 1 |a Cecka, Michael J.  |e VerfasserIn  |4 aut 
700 1 |a Opelz, Gerhard  |d 1944-  |e VerfasserIn  |0 (DE-588)1026480345  |0 (DE-627)726772453  |0 (DE-576)371826527  |4 aut 
700 1 |a Dreyer, Nancy A.  |e VerfasserIn  |4 aut 
700 1 |a Walker, Alexander M.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Pharmacoepidemiology and drug safety  |d Chichester [u.a.] : Wiley, 1992  |g 8(1999), 7, Seite 509-518  |h Online-Ressource  |w (DE-627)302467165  |w (DE-600)1491218-1  |w (DE-576)079719678  |x 1099-1557  |7 nnas  |a A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients 
773 1 8 |g volume:8  |g year:1999  |g number:7  |g pages:509-518  |g extent:10  |a A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients 
856 4 0 |u https://doi.org/10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210219 
993 |a Article 
994 |a 1999 
998 |g 1026480345  |a Opelz, Gerhard  |m 1026480345:Opelz, Gerhard  |d 910000  |d 911600  |e 910000PO1026480345  |e 911600PO1026480345  |k 0/910000/  |k 1/910000/911600/  |p 7 
999 |a KXP-PPN1748693662  |e 3864213460 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"10 S."}],"relHost":[{"note":["Gesehen am 28.02.08"],"disp":"A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patientsPharmacoepidemiology and drug safety","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"302467165","language":["eng"],"pubHistory":["1.1992 -"],"part":{"year":"1999","issue":"7","pages":"509-518","text":"8(1999), 7, Seite 509-518","volume":"8","extent":"10"},"title":[{"subtitle":"official journal of the International Society for Pharmacoepidemiology and the European Society of Pharmacovigilance","title":"Pharmacoepidemiology and drug safety","title_sort":"Pharmacoepidemiology and drug safety"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Chichester [u.a.]","dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisher":"Wiley"}],"id":{"issn":["1099-1557"],"zdb":["1491218-1"],"doi":["10.1002/(ISSN)1099-1557"],"eki":["302467165"]}}],"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"20 January 2000"}],"id":{"doi":["10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1"],"eki":["1748693662"]},"name":{"displayForm":["Hilal Maradit Kremers, Donnie P. Funch, Richard A. Robson, Michael A. Nalesnik, Shah Ebrahim, Michael J. Cecka, Gerhard Opelz, Nancy A. Dreyer, Alexander M. Walker"]},"note":["Gesehen am 19.02.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1748693662","title":[{"title_sort":"combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients","title":"A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients"}],"person":[{"family":"Maradit Kremers","given":"Hilal","roleDisplay":"VerfasserIn","display":"Maradit Kremers, Hilal","role":"aut"},{"family":"Funch","given":"Donnie P.","roleDisplay":"VerfasserIn","display":"Funch, Donnie P.","role":"aut"},{"given":"Richard A.","family":"Robson","role":"aut","roleDisplay":"VerfasserIn","display":"Robson, Richard A."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Nalesnik, Michael A.","given":"Michael A.","family":"Nalesnik"},{"family":"Ebrahim","given":"Shah","display":"Ebrahim, Shah","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Cecka","given":"Michael J.","roleDisplay":"VerfasserIn","display":"Cecka, Michael J.","role":"aut"},{"role":"aut","display":"Opelz, Gerhard","roleDisplay":"VerfasserIn","given":"Gerhard","family":"Opelz"},{"given":"Nancy A.","family":"Dreyer","role":"aut","roleDisplay":"VerfasserIn","display":"Dreyer, Nancy A."},{"role":"aut","display":"Walker, Alexander M.","roleDisplay":"VerfasserIn","given":"Alexander M.","family":"Walker"}]} 
SRT |a MARADITKRECOMBINATIO2020